Tong Ren Tang Sinopharm (03613) was issued a certificate of registration for proprietary Chinese medicines

According to Zhitong Finance App, Tong Ren Tang Sinopharm (03613) issued an announcement. The company recently received the “Certificate of Registration of Proprietary Chinese Medicines” (this certificate) issued by the Hong Kong Traditional Chinese Medicine Administration, permitting the sale of “Three Child Care Granules [Tong Ren Tang]” in the Hong Kong Special Administrative Region (Hong Kong) of the People's Republic of China.

The function of “Three Child Care Granules [Tongrentang]” is to warm the lungs and relieve phlegm, lower gas and digestion. It is used for symptoms of phlegm congestion, wheezing, excessive phlegm, chest pain, poor diet, white tongue, and smooth pulse. As of the date of this announcement, the Company has invested a total of approximately HK$800,000 (amount unaudited) in research and development of the “Three Child Care Granules [Tong Ren Tang]”, and the product has not yet been put on the market.

After obtaining this certificate, the “Three Child Care Granules [Tong Ren Tang]” produced by the company can be sold in Hong Kong, which helps to enrich the company's product line and facilitate its market expansion. Obtaining this certificate will not have a significant impact on the company's production, operation and performance for the time being. Pharmaceutical sales are easily affected by factors such as changes in the Hong Kong region's policy environment, exchange rate fluctuations, and market competition.